• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多次输血血液学患者血小板同种抗体的研究。

A study of platelet alloantibody in multiply-transfused haematology patients.

作者信息

Linn Y C, Prakash P, Ong Y W

机构信息

Department of Haematology, Singapore General Hospital.

出版信息

Ann Acad Med Singap. 1995 Mar;24(2):305-11.

PMID:7653976
Abstract

This paper studies the prevalence of platelet antibody in multiply-transfused leukaemia and other transfusion-dependent non-leukaemic patients, using a solid phase red cell adherence (SPRCA) assay and a microlymphocytotoxicity (LCT) test. A positivity rate of 26% in the leukaemic patients and 72% in non-leukaemic patients was obtained with the SPRCA assay, compared to a higher positivity rate of 69% and 83% in the respective groups using the LCT test. Several explanations are proposed. The lower sensitivity of the SPRCA assay suggests that the LCT test may need to be run concurrently for higher diagnostic yield. This paper also compares the performance between an in-house SPRCA test method and the commercial Capture P test kit, and good concordance was shown in repeated occasions.

摘要

本文采用固相红细胞吸附(SPRCA)试验和微量淋巴细胞毒性(LCT)试验,研究多次输血的白血病患者及其他依赖输血的非白血病患者中血小板抗体的流行情况。采用SPRCA试验时,白血病患者的阳性率为26%,非白血病患者为72%;而采用LCT试验时,相应组别的阳性率分别为69%和83%,后者更高。文中提出了几种解释。SPRCA试验较低的敏感性表明,可能需要同时进行LCT试验以提高诊断率。本文还比较了内部SPRCA检测方法与商业捕获P检测试剂盒的性能,多次检测显示两者具有良好的一致性。

相似文献

1
A study of platelet alloantibody in multiply-transfused haematology patients.多次输血血液学患者血小板同种抗体的研究。
Ann Acad Med Singap. 1995 Mar;24(2):305-11.
2
[Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
Beitr Infusionsther Transfusionsmed. 1996;33:47-54.
3
Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.输注储存前过滤的血小板和红细胞后同种异体HLA和非HLA抗体的发生:一项前瞻性研究。
Blood. 1995 Apr 1;85(7):1736-41.
4
Theoretic and practical aspects of platelet crossmatching.血小板交叉配型的理论与实践方面
Transfus Med Rev. 1990 Oct;4(4):265-78. doi: 10.1016/s0887-7963(90)70269-6.
5
Platelet-specific antibodies in transfused patients.输血患者中的血小板特异性抗体。
Eur J Haematol. 1996 Apr;56(4):248-51. doi: 10.1111/j.1600-0609.1996.tb01937.x.
6
Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
Zhonghua Yi Xue Za Zhi (Taipei). 1991 Apr;47(4):228-36.
7
[Prevention of HLA-alloimmunization of recipients of platelet concentrates].[预防血小板浓缩物接受者的HLA同种免疫]
Beitr Infusionsther. 1991;28:209-12.
8
Serological screening, using three different test systems of platelet-transfused patients with hematologic-oncologic disorders.对患有血液肿瘤疾病的血小板输注患者使用三种不同检测系统进行血清学筛查。
Vox Sang. 1993;65(2):108-13. doi: 10.1111/j.1423-0410.1993.tb02125.x.
9
Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test.仅在血小板免疫荧光试验中使用全血血小板才能检测到的抗HPA - 3a抗体引起的输血后紫癜。
Transfus Med. 2010 Jun;20(3):200-2. doi: 10.1111/j.1365-3148.2009.00978.x. Epub 2009 Nov 16.
10
Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching.血小板反应性抗体的流式细胞术检测及其在血小板交叉配型中的应用
Transfusion. 1996 Mar;36(3):250-5. doi: 10.1046/j.1537-2995.1996.36396182144.x.